Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “New Coronavirus Disease (COVID-19), Infection With SARS-CoV-2”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT04870164
What this trial is testing

Safety, Tolerability and PK of Ensovibep (MP0420 - a New Candidate With Potential for Treatment of COVID-19)

Who this might be right for
COVID-19
Molecular Partners AG 53
Large-scale testing (Phase 3)Study completedNCT04924660
What this trial is testing

Novel Experimental COVID-19 Therapies Affecting Host Response

Who this might be right for
COVID-19SARS-CoV-2 InfectionCoronavirus Infection
Sean Collins 1,060
Testing effectiveness (Phase 2)Study completedNCT04380688
What this trial is testing

Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.

Who this might be right for
COVID-19
AstraZeneca 62
Testing effectiveness (Phase 2)WithdrawnNCT04536090
What this trial is testing

Study of Isoquercetin (IQC-950AN) Plus Standard of Care Versus Standard of Care Only for the Treatment of COVID-19

Who this might be right for
COVID-19
Institut de Recherches Cliniques de Montreal
Testing effectiveness (Phase 2)Study completedNCT04540406
What this trial is testing

NBT-NM108 as an Early Treatment for Suspected or Confirmed Symptomatic COVID-19 Patients

Who this might be right for
Suspected or Confirmed COVID-19
Notitia Biotechnologies Company 42
Not applicableStudy completedNCT04794062
What this trial is testing

Myocardial Injury and Quality of Life After COVID-19

Who this might be right for
COVID-19Myocardial InjuryMyocarditis Post Infection
Voronezh Regional Clinical Consultative and Diagnostic Center 119
Not applicableStudy completedNCT04355351
What this trial is testing

Study of Immune Response During SARS-CoV-2 Infection - (COVID-19)

Who this might be right for
New Coronavirus Disease (COVID-19), Infection With SARS-CoV-2
Centre Hospitalier Universitaire de Nice 303
Post-approval studies (Phase 4)Study completedNCT05689827
What this trial is testing

Safety and Efficacy of the Therapy With BRAINMAX® for the Treatment of Patients With Asthenia After COVID-19

Who this might be right for
AstheniaCOVID-19
Promomed, LLC 160
Testing effectiveness (Phase 2)WithdrawnNCT04412252
What this trial is testing

Safety and Efficacy of Tofacitinib in Hospitalized Participants With COVID-19 Pneumonia Who Are Receiving Standard of Care Therapy

Who this might be right for
COVID-19
Pfizer
Not applicableUnknownNCT04351659
What this trial is testing

Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19

Who this might be right for
COVID-19
KK Women's and Children's Hospital 8
Testing effectiveness (Phase 2)WithdrawnNCT04325672
What this trial is testing

Convalescent Plasma to Limit Coronavirus Associated Complications

Who this might be right for
Coronavirus
Mayo Clinic
Testing effectiveness (Phase 2)UnknownNCT06288893
What this trial is testing

SHEN211 Tablets for the Treatment of Mild and Moderate Novel Corona Virus Infections (COVID-19)

Who this might be right for
COVID-19
JKT Biopharma Co., Ltd. 30
Not applicableUnknownNCT04724707
What this trial is testing

Russian Cardiovascular Registry of COVID-19

Who this might be right for
Covid19Acute Cardiovascular DiseaseCardiovascular Diseases
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health 900
Large-scale testing (Phase 3)UnknownNCT04558021
What this trial is testing

Evaluate The Efficacy And Safety Of a Novel Niclosamide Suspension Formulation For COVID-19

Who this might be right for
Covid19
Imuneks Farma ilac San. Tic. A.S. 200
Large-scale testing (Phase 3)Ended earlyNCT05593770
What this trial is testing

International Sites: Novel Experimental COVID-19 Therapies Affecting Host Response

Who this might be right for
COVID-19SARS-CoV2 InfectionCoronavirus Infection
NEAT ID Foundation 28
Not applicableLooking for participantsNCT04448145
What this trial is testing

Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence

Who this might be right for
COVID-19Corona Virus InfectionSARS-CoV 2
Columbia University 800
Large-scale testing (Phase 3)Study completedNCT04501783
What this trial is testing

Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID-19
R-Pharm 168
Post-approval studies (Phase 4)UnknownNCT04286503
What this trial is testing

The Clinical Study of Carrimycin on Treatment Patients With COVID-19

Who this might be right for
Novel Coronavirus Infectious Disease (COVID-19)
Beijing YouAn Hospital 520
Testing effectiveness (Phase 2)Ended earlyNCT04502433
What this trial is testing

Poractant Alfa (Curosurf®)) -- Effect in Adult Patients Diagnosed With 2019 Novel Coronavirus (SARS-COV-19; (Covid-19)) Acute Respiratory Distress Syndrome (ARDS)

Who this might be right for
Acute Respiratory Distress Syndrome
Chiesi Farmaceutici S.p.A. 22
Not applicableUnknownNCT05722678
What this trial is testing

Study and Analysis of Acute Pancreatitis Complicated With COVID-19

Who this might be right for
Acute Pancreatitis2019 Novel Coronavirus Infection
Yuansong Sun 30
Next Page